In addition, the encouraging results, obtained by the categories already associated with BCR-ABL1 and the newly described Rab family, could represent a starting point to dissect the contribution of other BCR-ABL1 putative modulators here identified in the etiology of CML (Table S2). This evidence concerns the gene AGFG1 and chronic myelogenous leukemia, BCR-ABL1 positive.